Area of research
Molecular Biology · Cardiology and Cardiovascular Medicine
Research interest
Research interests include Cardiac Fibrosis and Remodeling, Congenital heart defects research, Extracellular vesicles in disease, and Ubiquitin and proteasome pathways.
Mycn ameliorates cardiac hypertrophy-induced heart failure in mice by mediating the USP2/JUP/Akt/β-catenin cascade
Sevoflurane blocks KLF5‐mediated transcriptional activation of ITGB2 to inhibit macrophage infiltration in hepatic ischemia/reperfusion injury
Mesenchymal stem cells‐derived extracellular vesicle‐incorporated <scp>H19</scp> attenuates cardiac remodeling in rats with heart failure
ANP32B promotes lung cancer progression by regulating VDAC1
EZH2 mitigates the cardioprotective effects of mesenchymal stem cell-secreted exosomes against infarction via HMGA2-mediated PI3K/AKT signaling
Kruppel like factor 16 promotes lung adenocarcinoma progression by upregulating lamin B2
GM-CSF-mediated inducement of bone marrow MDSCs by TSA and effect on survival of graft in mice
Ginsenoside Rd ameliorates aflatoxin B1 induced apoptosis via governing antioxidative activity in H9C2 cells and 3D heart spheroids
GPR39 promotes cardiac hypertrophy by regulating the AMPK–mTOR pathway and protein synthesis
KLK11 promotes the activation of mTOR and protein synthesis to facilitate cardiac hypertrophy
Fabrication of Ag nanoparticles mediated by extract of plant and determination of the anti-human lung cancer effects
FBXW7 promotes pathological cardiac hypertrophy by targeting EZH2-SIX1 signaling
HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling
Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling
Individualized annuloplasty for treating Ebstein anomaly